Fundrise Innovation Fund Shares Plummet Amid Trading Squeeze

The Fundrise Innovation Fund (FRZE) has experienced a sharp decline in its stock price for the second consecutive day, falling 34% to $173 in New York. This pullback follows a 31% slump in the previous day's trading, capping a volatile week since its listing on the New York Stock Exchange (NYSE) on March 19.

The fund's stock price had surged to as high as $575 on Wednesday, representing a 3,000% increase from its estimated net asset value per share of $18.97. However, the recent reversal, which coincided with a short call from Citron Research, has resulted in a significant market correction.

Key Statistics:

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

• Current market value: $6 billion
• Net assets: $679 million
• Trading premium: 9 times the combined value of its private company holdings based on their last funding rounds

The trading squeeze is attributed to provisions that restrict most investors from selling shares in the first six months after listing, creating a buying frenzy that has driven up the stock price. This phenomenon is not unique to the Fundrise Innovation Fund, as other closed-end funds, such as Robinhood Ventures Fund I, have also experienced similar price surges.

Investment Landscape:

• SpaceX is reportedly readying to file for a potential $75 billion initial public offering (IPO) in the coming days.
• Anthropic PBC is eyeing a potential debut raising as much as $60 billion as soon as October.
• OpenAI is also mulling a plan to list as early as this year.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

The Fundrise Innovation Fund holds stakes in private tech firms, including Anthropic PBC (20.7% of assets) and SpaceX (5% of assets), as well as Databricks, OpenAI, Anduril, and Ramp. Investors need to be aware of the holdings and their stated values to make informed investment decisions.